All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

16:09, 24 June 2024 Victor talk contribs deleted page Patient Association: Finnish Throat and Mouth Cancer Association (Finland) (content was: "{{forpatients}} Go back to Finland page '''Primary purpose:''' To provide support, rehabilitation, and information to individuals with throat and mouth cancer and their families, including adaptation training, peer support, speech rehabilitation, and financial assistance. '''Cancer areas of interest:''' '''Contact information:''' [https://www.le-invalidit.fi/yhteyst...", and the only contributor was "Francine" (talk))
16:09, 24 June 2024 Victor talk contribs deleted page Patient Association: European Cancer Leagues (ECL) (European Union - wide Resources) (content was: "'''Primary purpose:''' To advocate for improved cancer control and care in Europe through collaboration and policy influence. '''Contact information:''' Information [https://www.cancer.eu/].", and the only contributor was "Francine" (talk))
14:48, 24 June 2024 Francine talk contribs deleted page Data Dictionary: The Registry of Specialized Health Care Activity (RAE-CMBD) (content was: "Go back to Database: The Registry of Specialized Health Care Activity (RAE-CMBD) (Spain) page Source: From 2016 onwards (Specialized Care Registry (RAE-CMBD)) [https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/D/rae-cmbd/rae-cmbd/manual-de-usuario/manual-de-usuario-rae click here to learn more] From 1997 onwards (CMBD-RAE historical series. Acute ho...", and the only contributor was "Francine" (talk))
14:35, 24 June 2024 Francine talk contribs created page Data Dictionary: The Registry of Specialized Health Care Activity (RAE-CMBD) (Created page with "Go back to Database: The Registry of Specialized Health Care Activity (RAE-CMBD) (Spain) page Source: From 2016 onwards (Specialized Care Registry (RAE-CMBD)) [https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/D/rae-cmbd/rae-cmbd/manual-de-usuario/manual-de-usuario-rae click here to learn more] From 1997 onwards (CMBD-RAE historical series. Acute hospitals) [https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/D/rae-cmbd/serie-hist...")
14:19, 24 June 2024 Victor talk contribs deleted page PMSI (content was: "[https://pubmed.ncbi.nlm.nih.gov/28544284/ [1]] '''Sponsor, manager or home institution:''' [https://www.atih.sante.fr/ Agence technique de l'information sur l'hospitalisation (ATIH)] and [https://assurance-maladie.ameli.fr/ Caisse Nationale de l'Assurance Maladie (CNAM)] '''Type of information:''' Admission date, duration of stay, main, related, and associate diagnoses cod...", and the only contributor was "Larysse" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page Oulu University Hospital Trials (content was: "'''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal can...", and the only contributor was "Woloski" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page Ospedale San Raffaele Trials (content was: "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard...", and the only contributor was "Woloski" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page Open PHMEV: complete database on hospital prescriptions for drugs delivered in the community (content was: "Go back to Open PHMEV: regional database on hospital prescriptions for drugs delivered in towns (France) page. Source: [https://www.assurance-maladie.ameli.fr/etudes-et-donnees/open-phmev-base-regionale]. {| class="wikitable" ! Medicament |- | ATC1 | Main Anatomical Group |- | L_ATC1 | Label ATC1 |- | ATC2 | Therapeutic Subgroup |- | L_ATC2 | Label ATC2 |- | ATC3 | Pharm...", and the only contributor was "Larysse" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page Open Damir: Complete Database on Health Insurance Expenditure (content was: "'''Sponsor, manager or home institution:''' [https://assurance-maladie.ameli.fr/ Caisse Nationale de l'Assurance Maladie (CNAM)] '''Type of information:''' Six axes of analysis: period, benefit, care organization, care recipient, performing healthcare professional, prescribing health professional. Four amount indicators: total expenditure, health insurance reimbursement basis...", and the only contributor was "Larysse" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page Novel Therapies and Diagnostic Methods (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page North Estonia Medical Centre Trials (content was: "'''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal adeno...", and the only contributor was "Woloski" (talk))
14:19, 24 June 2024 Victor talk contribs deleted page North Estonia Medical Centre OECI Criteria Compliance (content was: "'''DISCLAIMER:''' The Cancer Beacon Project has received a letter of support from the Organisation of European Cancer Institutes, but we do not speak on their behalf nor have any influence or say in the accreditation process. {| class="wikitable mw-collapsible" |+ class="nowrap" | 1. Structure of the cancer centre/institute – identifiable entity |- | ! scope="col" | CORE ! scope="col" | Compliance |- ! scope="row" | 1.1.CORE The cancer centre/institute has an identifiable go...")
14:18, 24 June 2024 Victor talk contribs deleted page Norrland's University Hospital (content was: "== Experts == <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> </div> == Learning Resources == <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> </div> == Cancer-related Patient Associations and Resources == <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> </div>", and the only contributor was "Francine" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page Netherlands Cancer Institute - Antoni van Leeuwenhoek Trials (content was: "'''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc. '''Intervention''': LN-145 '...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page Netherlands Cancer Institute (content was: "== Experts == <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> === Centers === '''[https://www.avl.nl/voorbereiding-afspraak/afdelingen-en-centra/avl-blaaskankercentrum/#afspraak Bladder cancer]''' '''[https://www.avl.nl/alles-over-kanker/kankersoorten/hersentumoren/ Brain tumor]''' '''[https://www.avl.nl/voorbereiding-afspraak/afdelingen-en-...", and the only contributor was "Francine" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page National Institute of Oncology Trials (content was: "'''NCTID''': NCT05169567 '''Title''': Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer '''Study Summary''': This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer tha...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page National Cancer Institute Trials (content was: "'''NCTID''': NCT03425643 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) '''Study Summary''': This trial will evaluate the safety and efficacy of pembrolizumab (MK-3...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page National Cancer Center Dresden Trials (content was: "'''NCTID''': NCT03430843 '''Title''': A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma '''Study Summary''': The purpose of this study is to evaluate the efficacy and safety of tislelizumab as second line treatment in participants with advanced unresectable/metastatic ESCC that h...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page Motol University Hospital Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematopoietic stem cell transpl...")
14:14, 24 June 2024 Victor talk contribs created page Beacon:About (Created page with "You can read about our methodology for collecting data here: Methodology.")
13:48, 24 June 2024 Victor talk contribs deleted page Mediterranean Institute of Oncology Trials (content was: "'''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in I...", and the only contributor was "Woloski" (talk))
13:48, 24 June 2024 Victor talk contribs deleted page Masaryk Memorial Cancer Institute Trials (content was: "'''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is not yet avai...", and the only contributor was "Woloski" (talk))
13:48, 24 June 2024 Victor talk contribs deleted page Maria Sklodowska- Curie National Research Institute of Oncology Trials (content was: "'''NCTID''': NCT03517137 '''Title''': Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study '''Study Summary''': The main objective of this trial is to assess whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma...", and the only contributor was "Woloski" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Léon Bérard Center Trials (content was: "'''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable L...", and the only contributor was "Woloski" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Lymphoma Association Flanders (Belgium) (content was: "Go back to Belgium page {{forpatients}} '''Primary purpose:''' To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease. '''Contact information:''' Information [https://www.lymfklierkanker.be/nl/contactformulier].", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (Kortrijk Cancer Centre AZ Groeninge) (content was: "=== Trainings: Symposia and Training === '''Primary purpose:''' To offer symposia and training opportunities tailored to various healthcare professionals. '''Target audience:''' Doctors, general practitioners, physiotherapists and related professionals. '''Access Information:''' Information [https://www.azgroeninge.be/nl/professionals/symposia-en-opleidingen]. === Event...", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (Brussels Cancer Centre - Centre du Cancer Bruxelles) (content was: "=== Training: Internship === '''Content type:''' Provide training on different areas of care, including oncology, under the supervision of experts. '''Target audience:''' Nurses, paramedics and psicologists. '''Access:''' Registration [https://www.uzbrusselwerkt.be/onze-vacatures/stagiairs].", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Latest Policymaking Initiatives (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Cancer Areas of Interest: Bulgarian National Cancer Registry (content was: "Go back to Bulgaria page Source: [https://sbaloncology.bg/index.php/bg/%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%82%D1%83%D1%80%D0%B0/%D0%BD%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D0%B5%D0%BD-%D1%80%D0%B0%D0%BA%D0%BE%D0%B2-%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%8A%D1%80/42-%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%82%D1%83%D1%80%D0%B0/%D0%BD%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D0%B5%D0%BD-%D1%80%D0%B0%D0%BA%D0%BE%D0%B2-%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%8A%D1%80/365-%D0%BE%...")
13:44, 24 June 2024 Victor talk contribs deleted page Database: National Cancer Registry (Bulgaria) (content was: "{{forresearchers}} Go back to Bulgaria page '''Primary purpose:''' Systematic collection, storage, organization, analysis, interpretation, publication and protection of data for persons with malignant neoplasms and carcinoma in situ throughout the country. '''Sponsor, manager or home institution:''' dataOwner::Bulgarian National Cancer Registry. '''Type of information:''' Data dictionary was not found. '''Available type of information:''' availableVariable::cancer...")
13:44, 24 June 2024 Victor talk contribs deleted page Database: Cancer Survival and Incidence in the Northern Region of Portugal (Portugal) (content was: "Go back to Portugal page {{forresearchers}} '''Primary purpose:''' Inform about cancer statistics regarding the south region of Portugal. Gathers information about the following districts: Braga, Bragança, Porto, Viana do Castelo and Vila Real. '''Sponsor, manager or home institution''': dataOwner::National Cancer Registry (RON) and dataOwner::Northern Regional...", and the only contributor was "Francine" (talk))
13:36, 24 June 2024 Francine talk contribs deleted page Data Dictionary: DRG Romania (content was: "{{forresearchers}} Go back to Database: Diagnosis Related Group (DRG) (Romania) page Source: [https://www.drg.ro/index.php?p=colaborare&s=model_analiza Click here to learn more] '''Indicators of clinical activity''' {| class="wikitable" ! Category ! Indicator |- | General indicators of activity volume and intensity | Number of cases |- | | Number of days of hospitalization |- | | Average duration of hospitalization |- | | Number of weighted cases |- | | Case complexi...")
13:11, 24 June 2024 Victor talk contribs deleted page Kortrijk Cancer Centre AZ Groeninge Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page '''NCTID''': NCT01332968 '''Title''': A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) '''Study Summary''': This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in...")
13:11, 24 June 2024 Victor talk contribs deleted page Karolinska Institute and University Hospital Trials (content was: "'''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in patients with advance...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page KCE Guidelines (Belgium) (content was: "{{forproviders}} Go back to Belgium page '''Primary purpose:''' Provides evidence-based recommendations for management, diagnosing, treating, and following up of many types of cancer. '''Sponsor, manager or home institution:''' dataOwner::Federaal Kenniscentrum voor de Gezondheidszorg. '''Type of information:''' availableVariable::cancer incidence, availableVariable::cancer survival, availableVariable::medical procedures for treatment and follow up of man...")
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Oncologico Veneto IRCCS-IOV Trials (content was: "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' Trials (content was: "'''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length of postoperative stay) after ele...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Investigation: Investigation Project (Instituto Português de Oncologia de Coimbra Francisco Gentil) (content was: "{{forproviders}} {{forresearchers}} Go back to Instituto Português de Oncologia de Coimbra Francisco Gentil page '''Primary purpose:''' To explore, analyze, and gather information about a specific topic, issue, or problem in order to generate insights, make informed decisions, develop solutions, and contribute to knowledge or innovation within a particular field or co...", and the only contributor was "Francine" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia do Porto Francisco Gentil Trials (content was: "'''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': Taiho Oncology, Inc. '''Intervention...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Lisboa Francisco Gentil Trials (content was: "'''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completel...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Coimbra Francisco Gentil Trials (content was: "'''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary''': The primary objective of the study is...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Echantillon généraliste de bénéficiaires (EGB) (content was: "[https://pubmed.ncbi.nlm.nih.gov/28544284/ [1]] '''Sponsor, manager or home institution:''' [https://assurance-maladie.ameli.fr/ Caisse Nationale de l'Assurance Maladie (CNAM)] '''Type of information:''' Identical to SNIIRAM, but on a smaller scale to be more manageable. Data structure is streamlined and simplified in the EGB. '''Source of Information:''' Includes data from...", and the only contributor was "Larysse" (talk))
12:47, 24 June 2024 Francine talk contribs deleted page Cancer areas of interest - DRG Romania (content was: "Go back to Romania page Source: [http://drg.ro/DocDRG/Lista_tabelara_a_diagnosticelor_RODRGv1.pdf] {| class="wikitable" |- ! Description || ICD code |- | Malignant tumors of the lip, oral cavity and pharynx || C00–C14 |- | Malignant tumors of esophagus || C15 |- | Malignant tumors of the stomach || C16 |- | Malignant tumors of the colon || C18 |- | Malignant tumor of the junction recto-sigmoid, rectum, anus and anal canal || C19–C21 |- | Malignant tumor of the liver...")
12:41, 24 June 2024 Francine talk contribs moved page Available type of information - DRG Romania to Available Data Dictionary - DRG Romania
02:08, 23 June 2024 Victor talk contribs deleted page Institute of Oncology Ljubljana Trials (content was: "'''NCTID''': NCT06060990 '''Title''': Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers '''Study Summary''': The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut du Cancer de Montpellier Trials (content was: "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''': Celgen...")
02:08, 23 June 2024 Victor talk contribs deleted page Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology Trials (content was: "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ducta...", and the only contributor was "Woloski" (talk))